Project Number 5R44AG063607-03 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Structurally Diverse GABA-A a5 Positive Allosteric Modulators for Treatment of MCI due to AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AGENEBIO, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-187: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $625,713 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
